The basic design was completed in March 2003 and then in June 2003 Baxter announced plans for the expansion that would result in 700 more new jobs – 400 as a direct result of the expansion and 300 coming from normal business growth – by 2006. By June 2004, one year after the expansion...
” Kandzari said. Not only that, “it also highlights how different these trials are from clinical practice.” For example, in SYMPLICITY HTN-3, patients in both the intervention and sham arms had, on average, eight points of contact where...
“Innovation in biotechnology is rapidly evolving to push the possibilities of advanced therapies, but the shortage of manufacturing capacity has resulted in delayed timelines and higher costs,” said Gary Schoenhouse, GeneSuites’ Chief Technical Advisor. “Catalyst BioCampus’ High-Performance Sh...